Grifols Partnership is a parenteral contract development and manufacturing platform (CDMO) focused on added value injectable products (small molecules), mainly in flexible bags, with a large international experience in the development and manufacturing of many types of sterile drug products. They are able to leverage the resources and experiences of the larger Grifols organization to provide significant value to their partners. Customers who have chosen Grifols as CDMO range from local, medium-sized pharmaceutical companies, to global industry leaders in the human and veterinary sectors.
Grifols Partnership is part of Grifols, a global company that since 1909 has enhanced the health and well-being of people around the world. Their four divisions - Bioscience, Diagnostic, Hospital, and Bio Supplies - develop, produce, and market innovative solutions and services in more than 100 countries. The company accomplishes this mission by producing proteins for patients who face sometimes life-threatening conditions and by providing hospitals, pharmacies, and healthcare professionals with the tools they need to enhance quality of life.